Physician profile
Nathan Kadavy
NPI 1972042141
$812.19
in general payments reported to CMS, 2019-2025
7 companies · $80.29 in 2025
The $80.29 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $318 · 2022: $164 · 2023: $193 · 2024: $56.06 · 2025: $80.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $329.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $404.26 | 2021-2023 | Menveo, Bexsero, Pediarix |
| Dexcom, INC. | $181.64 | 2023-2025 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Abbvie INC. | $88.76 | 2021-2023 | |
| Exact Sciences Corporation | $51.12 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbott Laboratories | $34.95 | 2024 | Freestyle Libre 3 |
| Lilly USA, LLC | $33.33 | 2025 | Mounjaro, Zepbound |
| Gilead Sciences, INC. | $18.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Kadavy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.